Bladder cancer: Keytruda is prescribed to adults to treat bladder cancer that’s: advanced or has spread from the bladder to other parts of the body. Keytruda is prescribed with the drug ...

The setback in bladder cancer is a small disappointment ... Combinations of Trodelvy and Keytruda have also advanced to late-stage testing against both breast and lung cancers.

Opens in a new tab or window The indication for sacituzumab govitecan (Trodelvy) in previously treated patients with locally advanced or metastatic urothelial cancer was withdrawn last month after ...

The withdrawal of the FDA accelerated approval for locally advanced or metastatic urothelial carcinoma, a type of bladder cancer, does not affect other indications of the therapy. The FDA has accepted ...

Keytruda is already approved for adjuvant ... a perioperative option in resectable stage IIA to IIIB NSCLC cases. Bladder cancer hopes back on track There was better news for Imfinzi this week ...

“The foundations of advanced bladder cancer treatment haven’t changed since the 1980s,” said Professor. Thomas Powles, Director of Barts Cancer Institute Biomedical Research Centre (QMUL ...

Rana R. McKay, MD, discusses the significance of clinical trial data for immunotherapy in muscle-invasive bladder cancer (MIBC) treatment she presented at a Case-Based Roundtable event.

After falling short in a confirmatory clinical trial, Gilead Sciences has decided to withdraw Trodelvy as a bladder cancer treatment in the U.S. The California biotech announced the decision ...

Padcev (enfortumab vedotin-ejfv) is a brand-name infusion prescribed for urothelial cancer (a type of bladder cancer ... in combination with pembrolizumab (Keytruda). In Padcev clinical trials ...

Bicycle Therapeutics (BCYC), a U.K.-based developer of a rival bladder cancer therapy called BT8009, fell sharply in reaction. According to detailed results, the Padcev/Keytruda combo led to a ...

The positive opinion comes just one week after Keytruda was approved by the Medicines and Healthcare products Regulatory Agency in combination with Astellas/Pfizer’s Padcev (enfortumab vedotin) as a ...

The Keytruda/Padcev combination already has accelerated ... of chemotherapy and immunotherapy in patients with metastatic bladder cancer,” said Dr Apolo, who noted that earlier trials of this ...